NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Deep Intelligent Pharma

Deep Intelligent Pharma

Private
SingaporeHealthcare & Life Scienceshttps://www.dip-ai.com/

Last Round

VC Round

Feb 2, 2026

Total Funding Raised

$105M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Deep Intelligent Pharma is a healthcare technology company that provides an AI-native platform to automate and optimize clinical trials for the pharmaceutical and biotech industries.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Workflow Automation, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

AI CROclinical trial automationdrug development AIpharma AIgenerative AImulti-agent systemAI medical writingregulatory submission automationin silico trialsclinical trial simulationprotocol design automationAI contract research organizationpharmacovigilance solutionseCTDsynthetic data generationelectronic common technical document

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Intelligent Pharma Comps

Public and private peers based on sector, stage, and business model.

Deep Intelligent Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deep Intelligent Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 2, 2026
Series DDec 11, 2025
Series DJan 19, 2024
Series BOct 9, 2018

Deep Intelligent Pharma Investors

Notable investors and investment history

Deep Intelligent Pharma investors
InvestorRounds
CDH BaifuSeries D
Kaitai CapitalSeries D, VC Round
Trustar CapitalVC Round
Xin Ding CapitalSeries D, VC Round
HongShanSeries D, Series B
CDH InvestmentsVC Round
JinYi CapitalSeries D, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Grew 22% QoQ, from 18 to 22 employees.

  • Feb 2, 2026

    $60M round led by Trustar Capital.

Deep Intelligent Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deep Intelligent Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deep Intelligent Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range25
Year Founded2017
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.